Search research articles
Contact Us
Filters
Showing results (61-70 of 79) with videos related to
Page
of 8
Sort By:
Current Research in Translational Medicine
|
February 22, 2022
Early prediction of renal graft function: Analysis of a multi-center, multi-level data set
Arturo Blazquez-Navarro, Chris Bauer, Nicole Wittenbrink, et al.
Kidney International
|
September 14, 2022
In vitro and in vivo evidence that the switch from calcineurin to mTOR inhibitors may be a strategy for immunosuppression in Epstein-Barr virus-associated post-transplant lymphoproliferative disorder
Constantin J Thieme, Malissa Schulz, Patrizia Wehler, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation
|
August 27, 2021
Risk factors for Epstein-Barr virus reactivation after renal transplantation: Results of a large, multi-centre study
Arturo Blazquez-Navarro, Chantip Dang-Heine, Patrizia Wehler, et al.
Kidney International
|
July 17, 2021
Superior cellular and humoral immunity toward SARS-CoV-2 reference and alpha and beta VOC strains in COVID-19 convalescent as compared to the prime boost BNT162b2-vaccinated dialysis patients
Arturo Blazquez-Navarro, Lema Safi, Toni L Meister, et al.
Molecular Therapy. Methods & Clinical Development
|
March 7, 2022
Tacrolimus-resistant SARS-CoV-2-specific T cell products to prevent and treat severe COVID-19 in immunosuppressed patients
Lena Peter, Désirée Jacqueline Wendering, Stephan Schlickeiser, et al.
Kidney International
|
October 7, 2021
Improved cellular and humoral immunity upon a second BNT162b2 and mRNA-1273 boost in prime-boost vaccination no/low responders with end-stage renal disease
Ulrik Stervbo, Arturo Blazquez-Navarro, Elena Vidal Blanco, et al.
Allergy
|
March 25, 2021
Detection of SARS-CoV-2-specific memory B cells to delineate long-term COVID-19 immunity
Constantin J Thieme, Mohamed Abou-El-Enein, Enrico Fritsche, et al.
Journal of the American Society of Nephrology : JASN
|
October 30, 2021
Impaired Humoral but Substantial Cellular Immune Response to Variants of Concern B1.1.7 and B.1.351 in Hemodialysis Patients after Vaccination with BNT162b2
Constantin J Thieme, Arturo Blazquez-Navarro, Lema Safi, et al.
Science Translational Medicine
|
January 14, 2021
The intratumoral CXCR3 chemokine system is predictive of chemotherapy response in human bladder cancer
Tino Vollmer, Stephan Schlickeiser, Leila Amini, et al.
Frontiers in Immunology
|
February 11, 2022
Immune Response in Moderate to Critical Breakthrough COVID-19 Infection After mRNA Vaccination
Krystallenia Paniskaki, Moritz Anft, Toni L Meister, et al.
Page
of 8
Search research articles
Search
Showing results (61-70 of 79) with videos related to
Sort By:
Page
of 8
Current Research in Translational Medicine
|
February 22, 2022
Early prediction of renal graft function: Analysis of a multi-center, multi-level data set
Arturo Blazquez-Navarro, Chris Bauer, Nicole Wittenbrink, et al.
Kidney International
|
September 14, 2022
In vitro and in vivo evidence that the switch from calcineurin to mTOR inhibitors may be a strategy for immunosuppression in Epstein-Barr virus-associated post-transplant lymphoproliferative disorder
Constantin J Thieme, Malissa Schulz, Patrizia Wehler, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation
|
August 27, 2021
Risk factors for Epstein-Barr virus reactivation after renal transplantation: Results of a large, multi-centre study
Arturo Blazquez-Navarro, Chantip Dang-Heine, Patrizia Wehler, et al.
Kidney International
|
July 17, 2021
Superior cellular and humoral immunity toward SARS-CoV-2 reference and alpha and beta VOC strains in COVID-19 convalescent as compared to the prime boost BNT162b2-vaccinated dialysis patients
Arturo Blazquez-Navarro, Lema Safi, Toni L Meister, et al.
Molecular Therapy. Methods & Clinical Development
|
March 7, 2022
Tacrolimus-resistant SARS-CoV-2-specific T cell products to prevent and treat severe COVID-19 in immunosuppressed patients
Lena Peter, Désirée Jacqueline Wendering, Stephan Schlickeiser, et al.
Kidney International
|
October 7, 2021
Improved cellular and humoral immunity upon a second BNT162b2 and mRNA-1273 boost in prime-boost vaccination no/low responders with end-stage renal disease
Ulrik Stervbo, Arturo Blazquez-Navarro, Elena Vidal Blanco, et al.
Allergy
|
March 25, 2021
Detection of SARS-CoV-2-specific memory B cells to delineate long-term COVID-19 immunity
Constantin J Thieme, Mohamed Abou-El-Enein, Enrico Fritsche, et al.
Journal of the American Society of Nephrology : JASN
|
October 30, 2021
Impaired Humoral but Substantial Cellular Immune Response to Variants of Concern B1.1.7 and B.1.351 in Hemodialysis Patients after Vaccination with BNT162b2
Constantin J Thieme, Arturo Blazquez-Navarro, Lema Safi, et al.
Science Translational Medicine
|
January 14, 2021
The intratumoral CXCR3 chemokine system is predictive of chemotherapy response in human bladder cancer
Tino Vollmer, Stephan Schlickeiser, Leila Amini, et al.
Frontiers in Immunology
|
February 11, 2022
Immune Response in Moderate to Critical Breakthrough COVID-19 Infection After mRNA Vaccination
Krystallenia Paniskaki, Moritz Anft, Toni L Meister, et al.
Page
of 8